본문 바로가기
KERD
논문KCI 등재

대추 물 추출물이 RANKL에 의해 유도되는 파골세포 분화에 미치는 영향

Inhibitory Effect on RANKL-Induced Osteoclast Differentiation by Water Extract of Zizyphus Jujuba Mill

백종민|오재민|김주영|이명수|천윤희|김정중|곽성철|이창훈|전병훈|최민규|윤강휴
한의병리학회 (The Society of Pathology in Korean Medicine)|2014.02|동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)|제28권 제1호|pp. 29-34

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

OsteoclastDifferentiationBone resorptionZizyphus Jujuba MillOsteoporosis Therapy
주제분류한의학

초록

Bone homeostasis is maintained by balance between bone resorbing-osteoclasts and bone forming-osteoblasts. Excessive osteoclastic bone resorption plays a critical role in bone destruction in pathological bone diseases such as osteoporosis, rheumatoid arthritis, and periodontal disease. Many compounds derived from natural products have pharmacological applications and have therapeutic value for treating or preventing several bone diseases characterized by excessive bone resorption. To discover new compounds that can act as anti-resorptive agents, we screened for natural compounds that regulate osteclast differentiation, and found that water extract of Ziziphus Jujuba Mill (WEZJ) has inhibitory effects on osteoclast differentiation. In this study, WEZJ clearly inhibits the osteoclast differentiation in the presence of receptor activator of nuclear factor kB (RANKL), macrophage colony-stimulating factor (M-CSF) without cytoxicity by blocking activation of nuclear factor of activated T cells (NFAT)c1, and c-Fos. In signaling pathway, the phosphorylation of Akt, p38, c-Jun N-terminal kinases (JNK), extracellular signal-regulated kinases (ERK) and the expression of osteoclast-associated receptor (OSCAR), tartrate-resistant acid phosphates (TRAP), Integrin av, Integrin b3, Cathepsin K are suppressed, too. These result suggest that WEZJ may have therapeutic value for treating or preventing several bone diseases characterized by excessive bone destruction.

Abstract

Bone homeostasis is maintained by balance between bone resorbing-osteoclasts and bone forming-osteoblasts. Excessive osteoclastic bone resorption plays a critical role in bone destruction in pathological bone diseases such as osteoporosis, rheumatoid arthritis, and periodontal disease. Many compounds derived from natural products have pharmacological applications and have therapeutic value for treating or preventing several bone diseases characterized by excessive bone resorption. To discover new compounds that can act as anti-resorptive agents, we screened for natural compounds that regulate osteclast differentiation, and found that water extract of Ziziphus Jujuba Mill (WEZJ) has inhibitory effects on osteoclast differentiation. In this study, WEZJ clearly inhibits the osteoclast differentiation in the presence of receptor activator of nuclear factor kB (RANKL), macrophage colony-stimulating factor (M-CSF) without cytoxicity by blocking activation of nuclear factor of activated T cells (NFAT)c1, and c-Fos. In signaling pathway, the phosphorylation of Akt, p38, c-Jun N-terminal kinases (JNK), extracellular signal-regulated kinases (ERK) and the expression of osteoclast-associated receptor (OSCAR), tartrate-resistant acid phosphates (TRAP), Integrin av, Integrin b3, Cathepsin K are suppressed, too. These result suggest that WEZJ may have therapeutic value for treating or preventing several bone diseases characterized by excessive bone destruction.

참고문헌 (28)

  1. Kanis, J.A., "Diagnosis of osteoporosis and assessment of fracture risk", Lancet, 359, pp.1929~1936 (2002)
  2. Bilezikian, J.P., "Estrogens and postmenopausal osteoporosis : was albright right after all?", J Bone Miner Res, 13, pp.774~776 (1998)
  3. Chen, F., "Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel", J Cell Biochem (2013)
  4. Oursler, M.J., "Direct and indirect effcets of estrogen on osteoclasts", J Musculoskelet Neuronal Interact, 3, pp.363~366 (2003)
  5. Ginaldi, L., "Osteoporosis, inflammation and ageing", Immun Ageing, 2, pp.14~ (2005)
  6. Cheng, M.H., "Osteoporosis treatment in postmenopausal women with pre-existing fracture", Taiwan J Obstet Gynecol, 51, pp.153~166 (2012)
  7. Khosla, S., "Benefits and risks of bisphosphonate therapy for osteoporosis", J Clin Endocrinol Metab, 97, pp.2272~2282 (2012)
  8. Kannel, K.A., "Adverse effects of bisphosphonates: implications for osteoporosis management", Mayo Clin Proc, 84, pp.632~638 (2009)
  9. Khosla, S., "Bisphosphonates-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research", J Bone Miner Res, 22, pp.1479~1491 (2007)
  10. Al-Reza, S.M., "Anti-inflammatory activity of seed essential oil from Zizyphus jujuba", Food Chem Toxicol, 48, pp.639~643 (2010)
  11. Gao, Q.H., "The jujube (Zizyphus jujuba Mill.) fruit: a review of current knowledge of fruit composition and health benefits", J Agric Food Chem, 61, pp.3351~3363 (2013)
  12. Phan, T.C., "Interaction between osteoblast and osteoclast; impact in bone disease", Histol Histophatol, 19, pp.1325~1344 (2004)
  13. Akesson, K., "New approaches to pharmacological treatment of osteoporosis", Bull World Health Organ, 81, pp.657~664 (2003)
  14. Ballanti, P., "Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry", Osteoporos Int, 7, pp.39~43 (1997)
  15. Chellaiah, M.A., "Regulation of actin ring formation by rho GTPases in osteoclasts", J Biol Chem, 280, pp.32930~32943 (2005)
  16. Roodman, G.D., "Regulation of osteoclast differentiation", Ann N Y Acad Sci, 1068, pp.100~109 (2006)
  17. Boyle, W.J., "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
  18. Li, X., "p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function", Endocrinology, 143, pp.3105~3113 (2002)
  19. Wada, T., "RANKL–RANK signaling in osteoclastogenesis and bone disease", Trends Mol Med, 12, pp.17~25 (2006)
  20. Takayanagi, H., "The role of NFAT in osteoclast formation", Ann N Y Acad Sci, 1116, pp.227~237 (2007)
  21. Boyce, B.F., "Roles for NF-kB and c-Fos in osteoclasts", J Bone Miner Metab, 23, pp.11~15 (2005)
  22. Nakamura, I., "Role of avb3 integrin in osteoclast migration and formation of the sealing zone", J Cell Sci, 112, pp.3985~3993 (1999)
  23. Rodan, S.B., "Integrin function in osteoclasts", J Endocrinol, 154, pp.S47~S56 (1997)
  24. Moissoglu, k., "Integrin Signalling in directed cell migration", Biol Cell, 98, pp.547~555 (2006)
  25. Wilson, S.R., "Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption", J Biol Chem, 284, pp.2584~2592 (2009)
  26. 백종민, "상기생 추출물이 파골세포 분화와 골흡수 억제에 미치는 효과", 동의생리병리학회지, 27(4), pp.431~436 (2013), 대한동의병리학회
  27. 곽성철, "골쇄보가 RANKL에 의해 유도되는 파골세포의 분화에 미치는 영향", 동의생리병리학회지, 26(4), pp.506~510 (2012), 대한동의병리학회[DOI]
  28. 천윤희, "파골세포 분화에 복령 추출물이 미치는 영향", 동의생리병리학회지, 26(3), pp.320~324 (2012), 대한동의병리학회[DOI]

관련 논문AI추천

오미자 물 추출물이 파골세포 분화에 미치는 영향리연, 송정훈, 이호섭, 장성조한의병리학회 · 동의생리병리학회지2010 · 제24권 제5호두충의 물 추출물이 파골세포의 분화에 미치는 영향곽한복, 송정훈, 오재민, 이명수, 이창훈, 장성조, 정연태, 조해중, 최윤홍한의병리학회 · 동의생리병리학회지2009 · 제23권 제3호파골세포의 분화와 뼈 흡수에 천남성의 억제 효과김하영, 박기인, 이명수, 이창훈한의병리학회 · 동의생리병리학회지2011 · 제25권 제1호白何首烏 물 추출물의 파골세포 분화에 미치는 영향문서영, 안용환, 오재민, 이명수, 전병훈, 정종혁, 채수욱, 최민규한의병리학회 · 동의생리병리학회지2012 · 제26권 제2호상기생 추출물이 파골세포 분화와 골흡수 억제에 미치는 효과김주영, 문서영, 백종민, 오재민, 이명수, 전병훈, 정우진, 최민규한의병리학회 · 동의생리병리학회지2013 · 제27권 제4호골쇄보가 RANKL에 의해 유도되는 파골세포의 분화에 미치는 영향곽성철, 곽한복, 김정중, 문서영, 오재민, 장성조, 전병훈, 최민규한의병리학회 · 동의생리병리학회지2012 · 제26권 제4호

이 간행물의 다른 논문 (18건)

당귀사역가오수유생강탕의 문헌적 고찰홍성인, 송윤경, 고호연, 전찬용, 정기용, 박종형, 이용현, 차윤엽, 김태훈, 박정수, 정종진, 선승호, 임은미, 고성규, 최유경pp. 1-8대만 중·서의 의료이원화 현황에 관한 연구- 면허제도 및 교육제도 확립을 중심으로 -권영규, 김동수, 권수현, 이현지, 최병희pp. 9-15미세침요법의 모발성장효과이지연, 정한솔, 신현종, 하기태, 이창현, 서형식pp. 16-21유방암세포에서 괴화 에탄올 추출물의 NF-kB 의존적인 MMP-9 발현의 조절 규명을 위한 연구박연주, 김정미, 김하림, 김미성, 황진기, 이영래, 류도곤, 권강범, 유용욱, 김성철pp. 22-28감잎의 광노화 피부 개선에 미치는 효과(2)오찬호, 유승정, 이창현, 신현종, 김명순, 마상용, 오미진, 최동성, 권진, 김남석pp. 35-44
원문 보기